SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-067823
Filing Date
2023-06-05
Accepted
2023-06-05 06:57:08
Documents
14
Period of Report
2023-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2317772d1_8k.htm   iXBRL 8-K 27216
2 EXHIBIT 99.1 tm2317772d1_ex99-1.htm EX-99.1 22724
6 GRAPHIC image_001.jpg GRAPHIC 4745
  Complete submission text file 0001104659-23-067823.txt   237727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA swtx-20230605.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20230605_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20230605_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2317772d1_8k_htm.xml XML 3497
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 23991197
SIC: 2836 Biological Products, (No Diagnostic Substances)